SEC Form 4 · accession 0001209191-16-142786
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward M. Kaye M.D.
Officer — President, CEO & CMO · Director
Period of report
Sep 22, 2016
Accepted (ET)
Sep 26, 2016 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 22, 2016 | M | 40,179 | $8.28 | A | 117,162 | D | |
| Common StockF1 | Sep 22, 2016 | S | 40,179 | $60.00 | D | 76,983 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Options (right to buy)F1 | $13.90 | Sep 22, 2016 | M | 40,179 | D | Jun 20, 2012 | Jun 20, 2021 | Common Stock | 40,179 | 40,179 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.